Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Porter

Showing results (1251-1260 of 1,284) with videos related to

Pageof 129
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitorsR P Alexander, G J Warrellow, M A W Eaton, et al.
JAMIA Open|July 24, 2024
Using publicly available, interactive epidemiological dashboards: an innovative approach to sharing data from the Rakai Community Cohort StudyKevin Footer, Camille M Lake, Joshua R Porter, et al.
Thorax|March 13, 2026
Randomised trial of delivering co-located, personalised stop-smoking support within lung cancer screening: the YESS studyRachael L Murray, David Baldwin, Kate Brain, et al.
Cancer Discovery|December 13, 2022
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance MutationsAlexander Drilon, Joshua C Horan, Anupong Tangpeerachaikul, et al.
American Journal of Human Genetics|October 18, 2000
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetesS Ghosh, R M Watanabe, T T Valle, et al.
Cancer Discovery|September 13, 2024
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound MutationsJessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Journal of Alzheimer'S Disease : JAD|November 17, 2025
A multi-modal medical management and lifestyle intervention increase cerebral blood flow and lowers diabetic risk in persons with early Alzheimer's disease: Mid-trial results from the PREVENTION trialJennifer E Bramen, Prabha Siddarth, Emily S Popa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthJennifer E Bramen, Prabha Siddarth, Emily S Popa, et al.
Ecology and Evolution|January 22, 2025
The Influence of Migration Timing and Local Conditions on Reproductive Timing in Arctic-Breeding BirdsW B English, B Lagassé, S Brown, et al.
Nature Microbiology|December 7, 2021
Rapid pathogen-specific recruitment of immune effector cells in the skin by secreted toxinsThuan H Nguyen, Gordon Y C Cheung, Kevin M Rigby, et al.
Pageof 129

Showing results (1251-1260 of 1,284) with videos related to

Sort By:
Pageof 129
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitorsR P Alexander, G J Warrellow, M A W Eaton, et al.
JAMIA Open|July 24, 2024
Using publicly available, interactive epidemiological dashboards: an innovative approach to sharing data from the Rakai Community Cohort StudyKevin Footer, Camille M Lake, Joshua R Porter, et al.
Thorax|March 13, 2026
Randomised trial of delivering co-located, personalised stop-smoking support within lung cancer screening: the YESS studyRachael L Murray, David Baldwin, Kate Brain, et al.
Cancer Discovery|December 13, 2022
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance MutationsAlexander Drilon, Joshua C Horan, Anupong Tangpeerachaikul, et al.
American Journal of Human Genetics|October 18, 2000
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetesS Ghosh, R M Watanabe, T T Valle, et al.
Cancer Discovery|September 13, 2024
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound MutationsJessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Journal of Alzheimer'S Disease : JAD|November 17, 2025
A multi-modal medical management and lifestyle intervention increase cerebral blood flow and lowers diabetic risk in persons with early Alzheimer's disease: Mid-trial results from the PREVENTION trialJennifer E Bramen, Prabha Siddarth, Emily S Popa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthJennifer E Bramen, Prabha Siddarth, Emily S Popa, et al.
Ecology and Evolution|January 22, 2025
The Influence of Migration Timing and Local Conditions on Reproductive Timing in Arctic-Breeding BirdsW B English, B Lagassé, S Brown, et al.
Nature Microbiology|December 7, 2021
Rapid pathogen-specific recruitment of immune effector cells in the skin by secreted toxinsThuan H Nguyen, Gordon Y C Cheung, Kevin M Rigby, et al.
Pageof 129